Dementia
Definition
- Memory problems
-
Mental loss that is severe enough to cause problems with one or more of the following:
- Language
- Visuospatial function
- Executive function (foresight, planning, anticipation, insight)
- Praxis (learned motor skills)
| Some Areas of the Brain Affected by Dementia |
|
| Copyright © Nucleus Medical Media, Inc. |
Causes
- Alzheimer's disease—the most common cause of dementia
- Brain damage after multiple small strokes (also called vascular dementia)
- Lewy body disease
- Alcoholism
- AIDS
- Multiple sclerosis
- Huntington's disease
- Parkinson's disease
- Creutzfeldt-Jakob disease and other prion disorders
- Front-temporal dementia (including Pick's disease)
- Normal pressure hydrocephalus
- Untreated syphilis
- Toxic levels of metals, such as aluminum (can sometimes occur in dialysis patients)
- Vitamin B12 deficiency
- Thiamine deficiency
- Thyroid dysfunction
Risk Factors
- Advancing age
- Family members with dementia
- Down syndrome
- Apolipoprotein E status (a genetic risk)
- Elevated cholesterol
- Multiple strokes
- High blood pressure
- Diabetes
- High cholesterol
- Obesity
- Lack of physical activity
- Vitamin deficiency
- Chronic drug use
- Long-term use of hormone replacement therapy
- Repetitive head trauma (may occur with contact sports)
- Overweight or obese
Symptoms
-
Increasing trouble remembering things, such as:
- How to get to familiar locations
- What the names of family and friends are
- Where common objects are usually kept
- How to do simple math
- How to do usual tasks, such as cooking, dressing, bathing, etc.
- How to drive
- How to pay bills
- Having difficulty concentrating on tasks
- Having difficulty completing sentences due to lost/forgotten words (may continue to a complete inability to speak)
- Forgetting the date, time of day, season
- Getting lost in familiar surroundings
- Having mood swings
- Being withdrawn, losing interest in usual activities
- Having personality changes
- Walking in a slow, shuffling way
- Having poor coordination
- Losing purposeful movement
Diagnosis
- An extensive medical history from you and your family
- Observing your behavior
- A physical exam
- Tests for your nervous system
- Mental status and psychological tests
- Blood tests—to look for syphilis, vitamin B12, folate, thiamine (B1) thyroid, liver, and kidney function
- CT scan—a type of x-ray that uses a computer to make pictures of structures inside the head
- MRI scan—a test that uses magnetic waves to make pictures of structures inside the head
- PET or SPECT scans—tests that use dyes to measure the activity levels of various areas of the brain (used in some cases)
- Lumbar puncture—a test of the fluid around the brain and spine to look for infection or bleeding, prion diseases, and potential markers of Alzheimer’s disease and other disorders
- Electroencephalogram (EEG)—a test that records the brain's activity by measuring electrical signals from the brain
Treatment
Medications
- Cholinesterase inhibitors—approved and recommended for mild to moderate Alzheimer's disease (such as donepezil [Aricept], rivastigmine [Exelon], galantamine [Reminyl])
- N-methyl-D-aspartate (NMDA) receptor antagonist—approved for moderate to severe Alzheimer's disease (such as memantine)
- Gamma-secretase inhibitors
- Tau fiber aggregation inhibitors
- Herbs and supplements (such as vitamin E, ginkgo biloba, huperzine A)—The evidence is mixed as to the effectiveness of these natural remedies.
Lifestyle Management
- Keeping you safe in your home
- Providing a calm, quiet, predictable environment
- Providing appropriate eyewear and hearing aids, easy-to-read clocks, and calendars
- Participating in music therapy and/or dance therapy
- Participating in physical and occupational therapy for daily activities
- Encouraging light exercise to reduce agitation and relieve depression
- Eating a healthy diet (such as Mediterranean diet)
- Discussing healthcare wishes with family members and doctors and appointing a healthcare proxy and a legal power of attorney
Psychiatric Medications
- Antidepressants
- Anxiolytics—to treat anxiety
-
Antipsychotics—to treat severe confusion, paranoia, and/or hallucinations
- Must be used with caution. Generally not recommended in people with dementia.
- These medications may cause an increased risk for stroke or death in elderly patients with dementia.
- Mood stabilizers—to treat dangerous or disruptive behaviors
Caregiver Support
Prevention
- Eat a healthy diet. This will help you to maintain good levels of vitamin B12 and cholesterol.
- Exercise regularly. This can also enhance cardiovascular health, which may delay the onset of vascular dementia.
- Alcohol may have some benefits if you use it in moderation. This means no more than two drinks per day for a man, and one drink per day for a woman. Moderate amounts of alcohol may decrease your risk of dementia. But higher amounts of alcohol can increase your risk of dementia.
- Avoid drug abuse and practice safe sex. This can reduce the risk of AIDS-related dementia.
- Engage in mentally stimulating activity. This may also reduce the risk of Alzheimer’s disease.
RESOURCES
Alzheimer's Association http://www.alz.org
American Academy of Neurology http://www.aan.com
CANADIAN RESOURCES
Alzheimers Association of Canada http://www.alzheimer.ca
Toronto Dementia Network http://www.dementiatoronto.org
References
Alzheimer's disease. EBSCO DynaMed website. Available at: https://dynamed.ebscohost.com/about/about-us. Updated July 11, 2012. Accessed August 22, 2012.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: http://www.nia.nih.gov/Alzheimers/Publications/medicationsfs.htm. Updated July 2010. Accessed August 22, 2012.
Alzheimer's disease and non-Alzheimer’s dementia. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/healthLibrary. Updated July 7, 2012. Accessed August 22, 2012.
Beers MH, Berkow R, Bogin RM, et al. The Merck Manual of Geriatrics. 3rd ed. Whitehouse Station, NJ: Merck & Co. Inc.; 1995-2000.
Cecil RL, Goldman L, Bennett JC. Cecil Textbook of Medicine. 21st ed. Philadelphia, PA: WB Saunders Company; 2000.
DeKosky S, Jeff D, Williamson A, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial JAMA. 2008;300:2253-2262.
Dementia evaluation. EBSCO DynaMed website. Available at: https://dynamed.ebscohost.com/about/about-us. Updated July 19, 2012. Accessed August 22, 2012.
American Academy of Neurology website. Available at: http://patients.aan.com/disorders/index.cfm?event=viewampdisorder%5Fid=844. Accessed August 22, 2012.
Gidoni R, et al. Cerebrospinal fluid biomarkers for Alzheimer’s disease: the present and the future. Neurodegen Dis. 2011;8:413-20.
Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomized clinical trials. BMJ. 2005;331:321-327.
Ledger AJ & Baker FA. An investigation of long-term effects of group music therapy on agitation levels of people with Alzheimer’s Disease. Aging & Mental Health. 2007;11: 330-338.
Mendez MF, Cummings JL. Dementia: A clinical Approach. 3rd ed. Boston, MA: Butterworth Heinemann; 2003.
Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66(10):1210-1215.
Obrien JT, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy Bodies. Arch Neurol. 2004; 61: 919-925.
Schneider L, Dagerman K, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934-1943.
Tierney L. Current Medical Diagnosis & Treatment. 44th ed. New York, NY: McGraw-Hill; 2005.
12/16/2008 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us: Farquhar C, Marjoribanks J, Lethaby A, Suckling J, Lamberts Q. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2008;CD004143.
2/24/2009 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us: Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;CD003120.
9/18/2009 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us: Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17:542-555.
1/8/2010 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us: Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009;302:2663-2670.
Digg
Del.icio.us
Yahoo
Google
Newsvine